Further experience with quingestanol acetate as a postcoital oral contraceptive
- PMID: 4613534
- DOI: 10.1016/0010-7824(74)90013-4
Further experience with quingestanol acetate as a postcoital oral contraceptive
Abstract
PIP: The experiences of 4 clinical research groups, 1 each in Mexico, Peru, Chile, and Argentina, using quingestanol acetate as a postcoital oral contraceptive is described. 2702 patients accumulated 18,531 cycles of postcoital therapy. In Mexico with a 800 mcg dose, the pregnancy rate was .6. In Chile and Peru at a dose of 750 mcg, pregnancy rates were over 20. Differences in selection of patients may account for part of the difference.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
